GlaxoSmithKline: key resistance at 1369p

GlaxoSmithKline, the pharmaceutical company, announced that annual profits be at the lower end of its forecast range, an expected decline of between 1% and 4%.

Charts (4)

GlaxoSmithKline, the pharmaceutical company, announced that annual profits be at the lower end of its forecast range, an expected decline of between 1% and 4%. The company said the pandemic hit demand in its vaccines business. However, GlaxoSmithKline reported a third quarter net profit of £1.24 billion, ahead of expectations, compared with £1.55 billion a year earlier. 

From a technical point of view, the stock price remains in a downtrend capped by its 20DMA. Prices have filled the bearish gap opened on the 22th of October and are resuming their down trend below the resistance at 1369p (internal trend line). The daily RSI remains capped by a declining trend line. A break below the swing low at 1324p would open the way to a further decline towards 1270p (Fib projection). Alternatively, a push above 1369p would call for a limited rise towards the resistance at 1430p.

Source: GAIN Capital, TradingView


More from Equities

From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.